Your browser doesn't support javascript.
loading
Medicinal Chemistry of Oligonucleotide Drugs - Milestones of the Past and Visions for the Future.
Hall, Jonathan; Ashkinadze, Anastasia; Becker, Jan Philipp; Laski, Artur; Manz, Eva-Maria; Moravcík, Stefan; Sjöström, Sebastian; Vincent, Mathilde.
  • Hall J; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. jonathan.hall@pharma.ethz.ch.
  • Ashkinadze A; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. anastasiia.ashkinadze@pharma.ethz.ch.
  • Becker JP; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. phil.becker@pharma.ethz.ch.
  • Laski A; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. artur.laski@pharma.ethz.ch.
  • Manz EM; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. eva-maria.manz@pharma.ethz.ch.
  • Moravcík S; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. smoravcik@ethz.ch.
  • Sjöström S; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. sjoestrs@ethz.ch.
  • Vincent M; Dept. Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich. mathilde.vincent@pharma.ethz.ch.
Chimia (Aarau) ; 76(5): 466-473, 2022 May 25.
Article en En | MEDLINE | ID: mdl-38069719
ABSTRACT
The oligonucleotide therapeutics field has blossomed in recent years, with thirteen approved drugs today and the promise of accelerated growth in coming years. Much of the progress in this field is due to advances in the medicinal chemistry of oligonucleotides,combined with a judicious choice of molecular targets and disease areas. In this perspective, we describe the growth of this new class of drugs highlighting selected milestones in oligonucleotide medicinal chemistry.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article